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Background
Spain is the European country with the biggest impact of
immigration in the last 5 years. The experience of antiret-
roviral therapy in the immigrant population has been lit-
tle studied in our country.
Methods
Retrospective cohort study in which all HIV+ immigrant
patients were included at a referral hospital in south-east-
ern Spain since January 1, 1998 to September 30, 2008.
We analyzed in immigrant patients experiencing HAART
therapy the following aspects: start of therapy, adherence,
and major toxicity events associated with HAART therapy.
Summary of results
95 HIV+ immigrant patients were enrolled. Eighty (84%)
received HAART therapy. No differences were observed (p
= ns) in the proportion of immigrant patients who
received HAART when it was compared to the native pop-
ulation (n = 242; 84%). The most commonly used antiret-
roviral agents at basal visit were: NRTI [3TC (64%); TDF
(33%); FTC (31%)], NNRTI [EFV (41%); NVP (15%)] and
PI [NFV (31%); LPV (11%)]. The main changes in the
HAART therapy were caused by: simplification (n = 16),
toxicity (n = 12) and therapeutic failure (n = 10). Adher-
ence to HAART therapy at the end of the follow-up was
good (> 95%) in 65 cases (81%), irregular (80%–95%) in
five cases (6.3%) and poor (<80%) in six cases (7.5%). No
significant differences were found in adherence to HAART
(>95%, 80%–95% or <80%) with regard to the native
population (n = 232; p = ns). Twenty-four episodes of tox-
icity to HAART were documented in 17 immigrant
patients: 11 cases of toxicity of antiretrovirals class [three
cases of lipoatrophy associated to NRTI, one case of toxi-
codermia associated to NNRTI, and nine cases associated
to PI (hypercholesterolemia, n = 2; hyperglycemia, n = 1;
hypertriglyceridemia, n = 5; and lipohypertrophy, n = 1)],
and seven cases of specific toxicity: renal impairment asso-
ciated to TDF and IDV (n = 2), hyperbilirubinemia due to
ATV (n = 2), CNS toxicity due to EFV (n = 1) and anemia
associated to AZT (n = 1).
Conclusion
In our cohort, most HIV+ immigrant patients were under
HAART therapy. The antiretroviral drugs most frequently
used in combination in immigrants were the NRTI and
NNRTI. Adherence was good in most of the immigrant
patients, without differences in relation to the native pop-
ulation. Toxicity was the second most common cause that
prompted the change in therapy after HAART therapy sim-
plification. The PI were the antiretroviral agents that
occurred more frequently in terms of toxicity of class or
family.
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